| Joan Bladé, Barcelona, Spain Giovanni Palladini, Pavia, Italy |
| Amyloidosis: Classification and Epidemiology Chair: Joan Bladé, Barcelona, Spain Speaker: Per Westermark, Uppsala, Sweden |
| Giampaolo Merlini: Aiming for the Cure of Amyloid Disease (Introduction by Joan Bladé) |
| Basic Science: Amyloid Fibril Formation, Deposition and Clearance Chairs: John Berk, Boston, MA, USA Francesca Lavatelli, Pavia, Italy Amyloid fibril structures using cryo EM and ssNMR Marcus Fändrich, Ulm, Germany Structural basis of amyloidogenicity Marina Ramírez-Alvarado, Rochester, MN, USA Drivers of amyloid organ tropism and deposition Gunilla Westermark, Uppsala, Sweden Tissue based diagnosis and classification of amyloidosis by mass spectrometry-based proteomics Ahmet Dogan, New York, NY, USA Proteotoxicity and organ damage Francesca Lavatelli, Pavia, Italy Cardiac amyloid regression by CMR in AL and ATTR amyloidosis Marianna Fontana, London, UK Development of amyloid disruptors for ATTR amyloidosis Mitsuharu Ueda, Kumamoto, Japan |
|
| 16:30 - 16:50 | Discussion |
| A Deeper Look at ATTR-CM: An Under-recognized and Life-threatening Illness Chair: Pablo García-Pavía, Madrid, Spain Mechanisms and Patterns of Cardiac Deposition in Amyloidosis Yukio Ando, Kumamoto, Japan Recognition and Diagnosis of ATTR Cardiomyopathy Claudio Rapezzi, Bologna, Italy Management of ATTR Cardiomyopathy Pablo García-Pavía, Madrid, Spain Panel Discussion and Q&A |
| AL amyloidosis: Diagnosis and Management in 2020 Chairs: Ashutosh Wechalekar, London, UK Stefan Schönland, Heidelberg, Germany Diagnosis work-up and typing Angela Dispenzieri, Rochester, MN, USA Red-flags for early diagnosis Ute Hegenbart, Heidelberg, Germany New prognostic markers Efstathios Kastritis, Athens, Greece Cytogenetics in AL amyloidosis Stefan Schönland, Heidelberg, Germany Hematologic and organ response criteria Giovanni Palladini, Pavia, Italy |
|
| 19:30 - 19:50 | Discussion |